RxDoctor Payments DataLook up a doctor →

HemiCAP Patella-Femoral XL: payments to doctors

Payments that named HemiCAP Patella-Femoral XL as the associated device or medical supply, reported under the Sunshine Act for program years 20192025.

Total reported
$125K
Providers
18
Transactions
27
Average per transaction
$4,623

The per-transaction average — $4,623 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 18 providers the average total is $6,934, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Arthrosurface Incorporated$100,70280.7%
Anika Therapeutics, Inc.$24,10919.3%

Other products from Arthrosurface Incorporated

The company that reported the most payments naming HemiCAP Patella-Femoral XL also reports against these.

← All drugs & devices